|Bid||79.93 x 900|
|Ask||79.84 x 800|
|Day's Range||77.98 - 80.82|
|52 Week Range||25.01 - 155.33|
|Beta (5Y Monthly)||2.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||97.16|
The analysts covering Sage Therapeutics, Inc. (NASDAQ:SAGE) delivered a dose of negativity to shareholders today, by...
It's been a good week for Sage Therapeutics, Inc. (NASDAQ:SAGE) shareholders, because the company has just released...
The call is being webcast live on the Investor and Media section of Sage's website at sagerx.com. This call is property of Sage Therapeutics and recording, reproduction or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited.